Gail V. Johnson - Publications

Affiliations: 
Cell Biology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Cell Biology, Molecular Biology, Neuroscience Biology

68 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Tapia-Rojas C, Cabezas-Opazo F, Deaton CA, Vergara EH, Johnson GVW, Quintanilla RA. It's all about tau. Progress in Neurobiology. PMID 30605723 DOI: 10.1016/j.pneurobio.2018.12.005  0.36
2016 Kim S, Choi KJ, Cho SJ, Yun SM, Jeon JP, Koh YH, Song J, Johnson GV, Jo C. Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors. Scientific Reports. 6: 24933. PMID 27112200 DOI: 10.1038/srep24933  0.64
2015 Pallo SP, DiMaio J, Cook A, Nilsson B, Johnson GV. Mechanisms of tau and Aβ-induced excitotoxicity. Brain Research. PMID 26731336 DOI: 10.1016/j.brainres.2015.12.048  0.64
2015 Chesser AS, Ganeshan V, Yang J, Johnson GV. Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons. Nutritional Neuroscience. PMID 26207957 DOI: 10.1179/1476830515Y.0000000038  0.64
2015 Pallo SP, Johnson GV. Tau facilitates Aβ-induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neurons. Neuroscience Letters. 597: 32-7. PMID 25888814 DOI: 10.1016/j.neulet.2015.04.021  0.64
2015 Zare-Shahabadi A, Masliah E, Johnson GV, Rezaei N. Autophagy in Alzheimer's disease. Reviews in the Neurosciences. PMID 25870960 DOI: 10.1515/revneuro-2014-0076  0.64
2014 Kim S, Lee D, Song JC, Cho SJ, Yun SM, Koh YH, Song J, Johnson GV, Jo C. NDP52 associates with phosphorylated tau in brains of an Alzheimer disease mouse model. Biochemical and Biophysical Research Communications. 454: 196-201. PMID 25450380 DOI: 10.1016/j.bbrc.2014.10.066  0.64
2014 Quintanilla RA, von Bernhardi R, Godoy JA, Inestrosa NC, Johnson GV. Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons. Neurobiology of Disease. 71: 260-9. PMID 25134729 DOI: 10.1016/j.nbd.2014.08.016  0.64
2014 Jo C, Kim S, Cho SJ, Choi KJ, Yun SM, Koh YH, Johnson GV, Park SI. Sulforaphane induces autophagy through ERK activation in neuronal cells. Febs Letters. 588: 3081-8. PMID 24952354 DOI: 10.1016/j.febslet.2014.06.036  0.64
2014 Eckert RL, Kaartinen MT, Nurminskaya M, Belkin AM, Colak G, Johnson GV, Mehta K. Transglutaminase regulation of cell function. Physiological Reviews. 94: 383-417. PMID 24692352 DOI: 10.1152/physrev.00019.2013  0.64
2014 Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GV. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nature Communications. 5: 3496. PMID 24667209 DOI: 10.1038/ncomms4496  0.36
2014 Olsen KC, Epa AP, Kulkarni AA, Kottmann RM, McCarthy CE, Johnson GV, Thatcher TH, Phipps RP, Sime PJ. Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules. American Journal of Respiratory Cell and Molecular Biology. 50: 737-47. PMID 24175906 DOI: 10.1165/rcmb.2013-0092OC  0.64
2013 Quintanilla RA, Jin YN, von Bernhardi R, Johnson GV. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease. Molecular Neurodegeneration. 8: 45. PMID 24330821 DOI: 10.1186/1750-1326-8-45  0.36
2013 Song Y, Kirkpatrick LL, Schilling AB, Helseth DL, Chabot N, Keillor JW, Johnson GV, Brady ST. Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules. Neuron. 78: 109-23. PMID 23583110 DOI: 10.1016/j.neuron.2013.01.036  0.64
2013 Jin YN, Yu YV, Gundemir S, Jo C, Cui M, Tieu K, Johnson GV. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin. Plos One. 8: e57932. PMID 23469253 DOI: 10.1371/journal.pone.0057932  0.64
2012 Jin YN, Chen PC, Watson JA, Walters BJ, Phillips SE, Green K, Schmidt R, Wilson JA, Johnson GV, Roberson ED, Dobrunz LE, Wilson SM. Usp14 deficiency increases tau phosphorylation without altering tau degradation or causing tau-dependent deficits. Plos One. 7: e47884. PMID 23144711 DOI: 10.1371/journal.pone.0047884  0.64
2012 Johnson KB, Petersen-Jones H, Thompson JM, Hitomi K, Itoh M, Bakker EN, Johnson GV, Colak G, Watts SW. Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2. American Journal of Physiology. Heart and Circulatory Physiology. 302: H1355-66. PMID 22307675 DOI: 10.1152/ajpheart.00918.2011  0.64
2012 Jin YN, Hwang WY, Jo C, Johnson GV. Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ. Plos One. 7: e30406. PMID 22276192 DOI: 10.1371/journal.pone.0030406  0.36
2012 Gundemir S, Colak G, Tucholski J, Johnson GV. Transglutaminase 2: a molecular Swiss army knife. Biochimica Et Biophysica Acta. 1823: 406-19. PMID 22015769 DOI: 10.1016/j.bbamcr.2011.09.012  0.64
2012 Quintanilla RA, Dolan PJ, Jin YN, Johnson GV. Truncated tau and Aβ cooperatively impair mitochondria in primary neurons. Neurobiology of Aging. 33: 619.e25-35. PMID 21450370 DOI: 10.1016/j.neurobiolaging.2011.02.007  0.64
2011 Dolan PJ, Jin YN, Hwang W, Johnson GV. Decreases in valosin-containing protein result in increased levels of tau phosphorylated at Ser262/356. Febs Letters. 585: 3424-9. PMID 21983102 DOI: 10.1016/j.febslet.2011.09.032  0.64
2011 Colak G, Filiano AJ, Johnson GV. The application of permanent middle cerebral artery ligation in the mouse. Journal of Visualized Experiments : Jove. PMID 21808231 DOI: 10.3791/3039  0.64
2011 Olsen KC, Sapinoro RE, Kottmann RM, Kulkarni AA, Iismaa SE, Johnson GV, Thatcher TH, Phipps RP, Sime PJ. Transglutaminase 2 and its role in pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine. 184: 699-707. PMID 21700912 DOI: 10.1164/rccm.201101-0013OC  0.64
2011 Pritchard SM, Dolan PJ, Vitkus A, Johnson GV. The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics. Journal of Cellular and Molecular Medicine. 15: 1621-35. PMID 21348938 DOI: 10.1111/j.1582-4934.2011.01273.x  0.64
2010 Dolan PJ, Johnson GV. The role of tau kinases in Alzheimer's disease. Current Opinion in Drug Discovery & Development. 13: 595-603. PMID 20812151  0.64
2010 Jin YN, Johnson GV. The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease. Journal of Bioenergetics and Biomembranes. 42: 199-205. PMID 20556492 DOI: 10.1007/s10863-010-9286-7  0.36
2010 Dolan PJ, Johnson GV. A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. The Journal of Biological Chemistry. 285: 21978-87. PMID 20466727 DOI: 10.1074/jbc.M110.110940  0.64
2010 Filiano AJ, Tucholski J, Dolan PJ, Colak G, Johnson GV. Transglutaminase 2 protects against ischemic stroke. Neurobiology of Disease. 39: 334-43. PMID 20451610 DOI: 10.1016/j.nbd.2010.04.018  0.64
2009 Beagle B, Mi K, Johnson GV. Phosphorylation of PPP(S/T)P motif of the free LRP6 intracellular domain is not required to activate the Wnt/beta-catenin pathway and attenuate GSK3beta activity. Journal of Cellular Biochemistry. 108: 886-95. PMID 19711366 DOI: 10.1002/jcb.22318  0.64
2009 Quintanilla RA, Johnson GV. Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease. Brain Research Bulletin. 80: 242-7. PMID 19622387 DOI: 10.1016/j.brainresbull.2009.07.010  0.36
2009 Quintanilla RA, Matthews-Roberson TA, Dolan PJ, Johnson GV. Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease. The Journal of Biological Chemistry. 284: 18754-66. PMID 19389700 DOI: 10.1074/jbc.M808908200  0.64
2009 Kong PJ, Kil MO, Lee H, Kim SS, Johnson GV, Chun W. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line. Neurological Research. 31: 77-83. PMID 18691453 DOI: 10.1179/174313208X331572  0.64
2008 Matthews-Roberson TA, Quintanilla RA, Ding H, Johnson GV. Immortalized cortical neurons expressing caspase-cleaved tau are sensitized to endoplasmic reticulum stress induced cell death. Brain Research. 1234: 206-12. PMID 18718455 DOI: 10.1016/j.brainres.2008.07.111  0.36
2008 Ding H, Johnson GV. The last tangle of tau. Journal of Alzheimer's Disease : Jad. 14: 441-7. PMID 18688096  0.36
2008 Quintanilla RA, Jin YN, Fuenzalida K, Bronfman M, Johnson GV. Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease. The Journal of Biological Chemistry. 283: 25628-37. PMID 18640979 DOI: 10.1074/jbc.M804291200  0.36
2008 Ding H, Dolan PJ, Johnson GV. Histone deacetylase 6 interacts with the microtubule-associated protein tau. Journal of Neurochemistry. 106: 2119-30. PMID 18636984 DOI: 10.1111/j.1471-4159.2008.05564.x  0.64
2008 Ding H, Johnson GV. New application of beta-galactosidase complementation to monitor tau self-association. Journal of Neurochemistry. 106: 1545-51. PMID 18498442 DOI: 10.1111/j.1471-4159.2008.05496.x  0.36
2008 Filiano AJ, Bailey CD, Tucholski J, Gundemir S, Johnson GV. Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 2662-75. PMID 18375543 DOI: 10.1096/fj.07-097709  0.64
2007 Ruan Q, Quintanilla RA, Johnson GV. Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin. Journal of Neurochemistry. 102: 25-36. PMID 17403029 DOI: 10.1111/j.1471-4159.2007.04491.x  0.36
2007 Mookherjee P, Quintanilla R, Roh MS, Zmijewska AA, Jope RS, Johnson GV. Mitochondrial-targeted active Akt protects SH-SY5Y neuroblastoma cells from staurosporine-induced apoptotic cell death. Journal of Cellular Biochemistry. 102: 196-210. PMID 17340627 DOI: 10.1002/jcb.21287  0.64
2007 Mi K, Johnson GV. Regulated proteolytic processing of LRP6 results in release of its intracellular domain. Journal of Neurochemistry. 101: 517-29. PMID 17326769 DOI: 10.1111/j.1471-4159.2007.04447.x  0.32
2007 Ruan Q, Johnson GV. Transglutaminase 2 in neurodegenerative disorders. Frontiers in Bioscience : a Journal and Virtual Library. 12: 891-904. PMID 17127346 DOI: 10.2741/2111  0.64
2006 Mi K, Johnson GV. The role of tau phosphorylation in the pathogenesis of Alzheimer's disease. Current Alzheimer Research. 3: 449-63. PMID 17168644  0.32
2006 Milakovic T, Quintanilla RA, Johnson GV. Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences. The Journal of Biological Chemistry. 281: 34785-95. PMID 16973623 DOI: 10.1074/jbc.M603845200  0.64
2006 Ding H, Matthews TA, Johnson GV. Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation. The Journal of Biological Chemistry. 281: 19107-14. PMID 16687396 DOI: 10.1074/jbc.M511697200  0.64
2006 Tucholski J, Roth KA, Johnson GV. Tissue transglutaminase overexpression in the brain potentiates calcium-induced hippocampal damage. Journal of Neurochemistry. 97: 582-94. PMID 16539654 DOI: 10.1111/j.1471-4159.2006.03780.x  0.64
2006 Mi K, Dolan PJ, Johnson GV. The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity. The Journal of Biological Chemistry. 281: 4787-94. PMID 16365045 DOI: 10.1074/jbc.M508657200  0.64
2005 Milakovic T, Johnson GV. Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. The Journal of Biological Chemistry. 280: 30773-82. PMID 15983033 DOI: 10.1074/jbc.M504749200  0.64
2005 Matthews TA, Johnson GV. 14-3-3Zeta does not increase GSK3beta-mediated tau phosphorylation in cell culture models. Neuroscience Letters. 384: 211-6. PMID 15963640 DOI: 10.1016/j.neulet.2005.04.101  0.64
2005 Hunter JM, Crouse AB, Lesort M, Johnson GV, Detloff PJ. Verification of somatic CAG repeat expansion by pre-PCR fractionation. Journal of Neuroscience Methods. 144: 11-7. PMID 15848234 DOI: 10.1016/j.jneumeth.2004.10.006  0.64
2005 Mi K, Johnson GV. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway. Journal of Cellular Biochemistry. 95: 328-38. PMID 15778991 DOI: 10.1002/jcb.20400  0.32
2005 Bailey CD, Tucholski J, Johnson GV. Transglutaminases in neurodegenerative disorders. Progress in Experimental Tumor Research. 38: 139-57. PMID 15746534 DOI: 10.1159/000084238  0.64
2005 Stoothoff WH, Johnson GV. Tau phosphorylation: physiological and pathological consequences. Biochimica Et Biophysica Acta. 1739: 280-97. PMID 15615646 DOI: 10.1016/j.bbadis.2004.06.017  0.64
2005 Stoothoff WH, Cho JH, McDonald RP, Johnson GV. FRAT-2 preferentially increases glycogen synthase kinase 3 beta-mediated phosphorylation of primed sites, which results in enhanced tau phosphorylation. The Journal of Biological Chemistry. 280: 270-6. PMID 15522877 DOI: 10.1074/jbc.M410061200  0.64
2004 Johnson GV, Stoothoff WH. Tau phosphorylation in neuronal cell function and dysfunction. Journal of Cell Science. 117: 5721-9. PMID 15537830 DOI: 10.1242/jcs.01558  0.64
2004 Suh MD, Park CH, Kim SS, Kil MO, Lee GH, Johnson GV, Chun W. Tissue transglutaminase is not involved in the aggregate formation of stably expressed alpha-synuclein in SH-SY5Y human neuroblastoma cells. Archives of Pharmacal Research. 27: 850-6. PMID 15460447  0.64
2004 Choo YS, Johnson GV, MacDonald M, Detloff PJ, Lesort M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Human Molecular Genetics. 13: 1407-20. PMID 15163634 DOI: 10.1093/hmg/ddh162  0.64
2004 Shelton SB, Krishnamurthy P, Johnson GV. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells. Journal of Neuroscience Research. 76: 110-20. PMID 15048935 DOI: 10.1002/jnr.20051  0.64
2004 Shelton SB, Johnson GV. Cyclin-dependent kinase-5 in neurodegeneration. Journal of Neurochemistry. 88: 1313-26. PMID 15009631  0.64
2004 Ruan Q, Lesort M, MacDonald ME, Johnson GV. Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway. Human Molecular Genetics. 13: 669-81. PMID 14962977 DOI: 10.1093/hmg/ddh082  0.64
2004 Milakovic T, Tucholski J, McCoy E, Johnson GV. Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. The Journal of Biological Chemistry. 279: 8715-22. PMID 14670969 DOI: 10.1074/jbc.M308479200  0.64
2004 Krishnamurthy PK, Johnson GV. Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model. The Journal of Biological Chemistry. 279: 7893-900. PMID 14660557 DOI: 10.1074/jbc.M311203200  0.64
2003 Tucholski J, Johnson GV. Tissue transglutaminase directly regulates adenylyl cyclase resulting in enhanced cAMP-response element-binding protein (CREB) activation. The Journal of Biological Chemistry. 278: 26838-43. PMID 12743114 DOI: 10.1074/jbc.M303683200  0.64
2002 Stoothoff WH, Bailey CD, Mi K, Lin SC, Johnson GV. Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta. Journal of Neurochemistry. 83: 904-13. PMID 12421363 DOI: 10.1046/j.1471-4159.2002.01197.x  0.64
2002 Tucholski J, Johnson GV. Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner. Journal of Neurochemistry. 81: 780-91. PMID 12065637 DOI: 10.1046/j.1471-4159.2002.00859.x  0.64
2002 Zhang J, Krishnamurthy PK, Johnson GV. Cdk5 phosphorylates p53 and regulates its activity. Journal of Neurochemistry. 81: 307-13. PMID 12064478 DOI: 10.1046/j.1471-4159.2002.00824.x  0.64
2002 Lesort M, Chun W, Tucholski J, Johnson GV. Does tissue transglutaminase play a role in Huntington's disease? Neurochemistry International. 40: 37-52. PMID 11738471 DOI: 10.1016/S0197-0186(01)00059-6  0.64
2000 Guttmann RP, Johnson GV. Measurement of calpain activity in vitro and in situ using a fluorescent compound and tau as substrates Methods in Molecular Biology (Clifton, N.J.). 144: 143-150. PMID 10818759  0.64
Show low-probability matches.